Altria(MO)
Search documents
Dividend Harvesting Portfolio Week 248: $24,800 Allocated, $2,770.78 In Projected Dividends
Seeking Alpha· 2025-12-05 13:42
Core Viewpoint - The article emphasizes a personal investment strategy focused on growth and dividend income, aiming for an easy retirement through a portfolio that prioritizes compounding dividend income and growth [1]. Group 1: Investment Strategy - The strategy involves creating a portfolio that generates monthly dividend income, which is enhanced through dividend reinvestment and annual increases [1]. - The author holds long positions in several stocks, including MO, BST, ADX, VZ, and AGNC, either through stock ownership, options, or other derivatives [1]. Group 2: Personal Insights - The article reflects the author's personal opinions and is not intended as professional investment advice [2]. - It highlights the importance of conducting individual research to determine if the discussed companies align with personal investment objectives and financial situations [2].
Altria Group, Inc. (NYSE: MO) Price Prediction and Forecast 2025-2030 (December 2025)
247Wallst· 2025-12-03 13:00
Shares of Altria Group Inc. ( NYSE: MO )Â gained 3.79% over the past month after plummeting 14.25% the month prior. ...
Can Altria Sustain EPS Gains as Revenues Decrease 1.7% Y/Y?
ZACKS· 2025-12-02 16:16
Core Insights - Altria Group, Inc. achieved a 3.6% growth in adjusted earnings per share (EPS) to $1.45 in Q3 2025, despite a 1.7% year-over-year decline in revenues to $5.25 billion, indicating resilience in earnings amid revenue challenges [1][8] Financial Performance - The adjusted operating companies income in the smokeable segment increased by 0.7%, driven by pricing gains and lower per-unit settlement charges, even as domestic cigarette shipment volumes fell over 8% [2] - Adjusted operating margins in smokeables expanded by 130 basis points to 64.4%, which helped mitigate the impact of lower shipment volumes [2] - The oral tobacco segment also saw adjusted margins improve by 240 basis points to 69.2%, despite a 4.3% decline in segment revenues [2] Share Repurchase Impact - Share repurchases significantly contributed to EPS growth, with the company buying back 1.9 million shares in the quarter and retiring a total of 12.3 million shares over the first nine months of the year [3][4] Comparison with Peers - In contrast, Philip Morris International Inc. reported a 17.3% year-over-year growth in adjusted EPS, supported by a 9.4% increase in net revenues, benefiting from strong pricing and rising volumes in smoke-free products [5] - Turning Point Brands, Inc. experienced a 31.2% growth in consolidated net sales and an 18.3% increase in net income, reflecting strong momentum in modern oral products [6] Valuation Metrics - Altria's shares have increased by 4.4% over the past month, while the industry average growth was 8.6% [7] - The company trades at a forward price-to-earnings ratio of 10.65X, which is lower than the industry average of 14.52X [9] Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 EPS has increased by 1 cent to $5.44, while the estimate for 2026 has decreased by 1 cent to $5.56 [10]
Is Altria Group Too Cheap to Ignore at Today's Price?
The Motley Fool· 2025-11-28 08:41
Core Viewpoint - Altria Group's shares may have further room to decline before reaching deep-value territory, despite appearing undervalued based on low forward P/E and high dividend yield [1][9]. Financial Performance - Current stock price is $58.69 with a market cap of $99 billion, and a forward P/E ratio of 10.4, significantly lower than Philip Morris International's 18.5 [2][9]. - Altria's gross margin stands at 71.98% and the dividend yield is 7.02% [2]. Sales and Shipment Volumes - Marlboro-branded shipment volumes fell by 11.7%, indicating a potential shift of smokers to lower-priced brands or alternatives [4][5]. - Shipment volumes for smokeless tobacco brands Skoal and Copenhagen decreased by 17.1% and 12.4%, respectively, while on! nicotine pouch volumes only increased by 0.7% [6]. Market Reaction - Following a quarterly earnings release, Altria's shares dropped nearly 8% due to disappointing shipment volumes and weak guidance updates [7]. - Despite a slight recovery, shares remain at risk of further volatility [7]. Competitive Landscape - Altria's revenue from alternative products is only 14%, compared to 41% for Philip Morris and 18.2% for British American Tobacco, indicating a slower transition to smoke-free products [10][11]. - The current valuation of Altria may not expand unless significant changes occur in its sales volumes or product diversification strategies [12]. Investment Strategy - Investors are advised to wait for lower prices or significant changes in Altria's strategy before considering buying the stock [8][14]. - Potential catalysts for change could include breakthroughs in collaborations or mergers that enhance smoke-free product exposure [14].
MO vs. PM: Which Tobacco Giant Is Winning the Smoke-Free Race?
ZACKS· 2025-11-27 16:11
Core Insights - Altria Group, Inc. and Philip Morris International Inc. are key players in the global tobacco industry, each with distinct strategies and strong brand portfolios [1][2] - The tobacco industry is transforming due to declining cigarette use, regulatory pressures, and consumer interest in smoke-free technologies, prompting both companies to innovate and restructure [2] Altria Group, Inc. (MO) - Altria holds a dominant position in the U.S. tobacco market with a 45.4% cigarette retail share and Marlboro's 59.6% share in the premium segment as of Q3 2025 [3] - The smokeable segment achieved a 64.4% adjusted operating companies income margin, indicating strong pricing power despite volume pressures [3] - Altria's strategy includes enhancing profitability while expanding into oral nicotine, heated tobacco, and e-vapor platforms, with on! shipments reaching 133.6 million cans year-to-date [4] - The company raised its quarterly dividend by 3.9% to $1.06 per share, marking its 60th increase in 56 years, and expanded its share repurchase program to $2 billion through 2026 [5] - Domestic cigarette shipment volumes fell 8.2% in the quarter, and Marlboro's total-category share declined to 40.4%, highlighting ongoing challenges [6] Philip Morris International Inc. (PM) - Philip Morris is focused on smoke-free products, which accounted for 41% of total net revenues and 42% of gross profit in Q3 2025, with smoke-free gross profit reaching a record $3.1 billion [7][8] - Shipments of IQOS increased by 15.5% to 40.8 billion units, maintaining a 76% global share of heated tobacco units [8] - Adjusted operating income rose 12.4% to $4.7 billion, with margins expanding to 43.1%, and adjusted EPS increased 17.3% to $2.24 [10] - Despite a 3.2% decline in cigarette shipment volumes, pricing strength lifted net revenues by 4.3% [11] Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 EPS indicates a year-over-year increase of around 6.3%, with the 2025 EPS estimate at $5.44 [12] - For Philip Morris, the 2025 EPS estimate implies a year-over-year growth of 14.3%, with the estimate at $7.51 [14] Stock Performance - Over the past year, Altria's shares gained 9.3%, while Philip Morris's shares advanced by 22.7% [16] - Altria trades at a forward P/E ratio of 10.57, while Philip Morris's forward P/E ratio stands at 18.9 [18] Investment Outlook - Philip Morris is viewed as the stronger growth story due to its shift towards smoke-free products and disciplined cost strategy, while Altria offers stability and consistent cash flows [20]
Quality Dividends On Clearance: Secure +7% Yields Today
Seeking Alpha· 2025-11-25 12:35
Group 1 - Retailers are launching "pre-Black Friday" deals to attract consumers and capitalize on the excitement of discounted prices [1] - The focus of the campaigns is to encourage spending during the holiday shopping season [1] Group 2 - Rida Morwa, with over 35 years of experience in investment banking, leads the Investing Group High Dividend Opportunities [1] - The service aims for a targeted safe yield of +9% through high-yield investments [1] - Features of the service include model portfolios, buy/sell alerts, and regular market updates [1]
Is Altria Group Stock Underperforming the S&P 500?
Yahoo Finance· 2025-11-25 10:53
Core Insights - Altria Group, Inc. is a major consumer goods company focused on tobacco products, with a portfolio that includes the well-known Marlboro brand and extends to smokeless tobacco, wines, and alternative nicotine ventures [1] Company Overview - Altria's market capitalization is approximately $97.7 billion, categorizing it as a large-cap company, which allows for extensive distribution through wholesalers and major retail organizations [2] Stock Performance - Altria's stock has experienced significant volatility, falling over 16.4% from its 52-week high of $68.80 on August 22, and declining 15.3% in the past three months, contrasting with a 3.7% gain in the S&P 500 Index during the same period [3] - Over the past 52 weeks, Altria's stock gained only 1.1%, while year-to-date (YTD) it rose 9.6%, compared to the broader index's 11% increase over the past year and 14% YTD, indicating a notable performance gap [4] Technical Analysis - The momentum for Altria's stock has turned bearish, as it fell below its 200-day moving average in late October and has remained under the 50-day moving average since mid-October [5] Earnings Report - In the fiscal 2025 Q3 earnings report released on October 30, Altria's adjusted EPS increased by 3.6% year-over-year to $1.45, slightly exceeding analysts' expectations of $1.44. However, revenue for the quarter was $6.07 billion, which, despite surpassing forecasts, represented a 3% year-over-year decline due to lower net revenues in smokeable products, contributing to a 7.8% drop in share price on the announcement day [6]
How This 'Hidden Gold Mine' Has Beaten The Market For 30 Years
Benzinga· 2025-11-24 18:19
Core Insights - Corporate spin-offs have consistently outperformed the market for 30 years, creating significant investment opportunities [1][32][35] Historical Performance - Research from 1964 to 1990 indicated that spin-offs delivered average excess returns of 3.0% on ex-dates and outperformed the overall market by 10% in their first three years [2][3] - An updated study covering 2007 to 2017 confirmed that spin-offs maintained similar abnormal returns, indicating a persistent market inefficiency [3] Mechanisms of Outperformance - Indiscriminate selling by shareholders who receive spin-off shares often depresses prices below intrinsic value, creating opportunities for investors [29] - Spin-off management teams can make operational improvements without corporate bureaucracy, leading to better capital allocation and focused strategies [30] - The separation of complex conglomerates reveals hidden value, allowing for clearer valuation of individual businesses [31] Notable Spin-off Examples - Yum Brands, spun off from PepsiCo, achieved a total shareholder return of over 1,600% since its spin-off in 1997, compared to the S&P 500's 280% return [9][10] - Chipotle, spun off from McDonald's, saw its stock rise from $22 to $1,592.25, a gain of over 7,100% since its IPO [12] - Abbott Laboratories and AbbVie both performed well post-separation, with AbbVie returning about 20.1% per year since its debut [14][15] - Ferrari's stock rose tenfold after its spin-off from Fiat Chrysler, highlighting the value unlocked through separation [18] - Phillips 66 doubled in size within two years of its spin-off from ConocoPhillips, demonstrating the benefits of operational focus [19][20] Current Market Trends - The average market value of spin-offs has increased from around $1 billion before 2008 to $2.5 billion today, indicating a trend towards larger and more impactful separations [24][25] - Activist investors are increasingly advocating for spin-offs, as seen in campaigns targeting companies like Honeywell and General Electric [26][27] Future Opportunities - Spin-offs remain a fertile ground for outsized returns, but require thorough analysis and patience from investors [34][35] - Recent spin-offs like Solstice Advanced Materials and Qnity Electronics are positioned to benefit from strong market trends, including demand for cooling systems and semiconductor materials [37][42]
Altria Narrows 2025 EPS Outlook: Is Margin Growth Peaking?
ZACKS· 2025-11-24 16:21
Core Insights - Altria Group, Inc. has narrowed its 2025 adjusted earnings per share outlook to $5.37-$5.45, reflecting operational discipline and clearer margin performance expectations [1][4][8] Financial Performance - The smokeable segment achieved adjusted operating income margins of 64.4%, an increase of 1.3 percentage points, driven by pricing and lower per-unit settlement charges [2][8] - Domestic cigarette volumes declined approximately 9% in Q3 2025, compared to an estimated 8% decrease at the industry level [2] - Oral tobacco margins rose to 69.2%, up 2.4 percentage points, influenced by mix shifts and promotional activities [3][8] Competitive Landscape - Philip Morris International Inc. reported an adjusted operating income margin of 43.1%, up 1.2 percentage points year over year, with smoke-free gross profit increasing by 19.5% [5] - Turning Point Brands, Inc. saw gross margins in the Stoker's segment rise to 60.2%, an expansion of 440 basis points year over year, driven by strong Modern Oral momentum [6] Valuation Metrics - Altria's shares have decreased by 10% over the past month, while the industry has declined by 1.7% [7] - The forward price-to-earnings ratio for Altria is 10.48X, compared to the industry average of 14.17X [9] - The Zacks Consensus Estimate for Altria's 2025 earnings per share has increased by 1 cent to $5.44, while the estimate for 2026 has decreased by 1 cent to $5.56 [10]
Looking For Yields: Merck, Altria, And Genuine Parts Are Consistent Moneymakers
Yahoo Finance· 2025-11-22 03:01
Core Insights - Companies with a strong history of dividend payments and increases are attractive to income-focused investors, with Merck, Altria, and Genuine Parts recently announcing dividend hikes and offering yields up to 7% [1] Merck - Merck & Co. has raised its dividends for 14 consecutive years, with the latest increase on Nov. 19 raising the quarterly payout from $0.77 to $0.81 per share, resulting in an annual figure of $3.24 per share [3] - The current dividend yield for Merck is 3.49% [3] - As of Sept. 30, Merck's annual revenue was $64.23 billion, and Q3 2025 revenues were reported at $17.28 billion with an EPS of $2.58, both exceeding consensus estimates [4] Altria - Altria Group has a remarkable track record of increasing dividends for 56 years, with the most recent hike on Aug. 21 raising the quarterly payout from $1.02 to $1.06 per share, equating to an annual figure of $4.24 per share [5] - The current dividend yield for Altria is 7.29% [5] - Altria's annual revenue as of Sept. 30 was $20.17 billion, with Q3 2025 revenues of $6.07 billion and an EPS of $1.45, both surpassing consensus estimates [6] Genuine Parts - Genuine Parts Co. has consistently raised its dividends for 69 years, with the latest increase on Feb. 18 raising the quarterly payout by 3% to $1.03 per share, resulting in an annual figure of $4.12 per share [8] - The current dividend yield for Genuine Parts is 3.24% [8]